Antibiotic Resistance

Soligenix Inc. Advances Novel Immunotherapy to Combat Antibiotic Resistance

Soligenix Inc. is developing SGX943, a novel immunotherapy that enhances the body's immune response to combat bacterial infections, addressing the critical challenge of antibiotic resistance.